VEEVA SYSTEMS INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that VEEVA SYSTEMS INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 31, 2020 | $311.51M | Mar 30, 2020 |
| FY2020 | Oct 31, 2019 | $280.92M | Mar 30, 2020 |
| FY2020 | Jul 31, 2019 | $266.90M | Mar 30, 2020 |
| FY2020 | Apr 30, 2019 | $244.75M | Mar 30, 2020 |
| FY2020 | Jan 31, 2019 | $232.32M | Mar 30, 2020 |
| FY2020 | Oct 31, 2018 | $224.73M | Mar 30, 2020 |
| FY2020 | Jul 31, 2018 | $209.61M | Mar 30, 2020 |
| FY2020 | Apr 30, 2018 | $195.55M | Mar 30, 2020 |
| FY2019 | Jan 31, 2018 | $185.98M | Mar 28, 2019 |
| FY2019 | Oct 31, 2017 | $177.01M | Mar 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $3.20B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $2.75B | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $2.36B | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $2.16B | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $1.85B | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | $396.76M | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | $377.52M | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | $353.68M | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | $337.11M | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | $311.51M | Mar 30, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $2.41B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $2.05B | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $1.69B | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $1.55B | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $1.35B | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | $282.91M | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | $274.52M | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | $256.48M | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | $242.23M | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | $217.19M | Mar 30, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $908.91M | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $714.14M | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $525.71M | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $487.71M | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $427.39M | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | $102.92M | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | $96.96M | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | $93.55M | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | $86.57M | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | $66.18M | Mar 30, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $916.37M | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $691.44M | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $429.33M | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $459.09M | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $505.50M | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | $98.84M | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | $101.31M | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | $90.08M | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | $87.57M | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | $60.39M | Mar 30, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $767.39M | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $693.08M | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $629.03M | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $520.28M | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $382.04M | Mar 25, 2024 |
| FY2023 | Jan 31, 2021 | $294.22M | Mar 30, 2023 |
| FY2021 | Jan 31, 2020 | $209.90M | Mar 30, 2022 |
| FY2021 | Jan 31, 2019 | $158.78M | Mar 30, 2021 |
| FY2020 | Jan 31, 2018 | $132.02M | Mar 30, 2020 |
| FY2019 | Jan 31, 2017 | $96.74M | Mar 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.42B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $1.09B | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $911.34M | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $780.47M | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $764.46M | Mar 25, 2024 |
| FY2023 | Jan 31, 2021 | $551.25M | Mar 30, 2023 |
| FY2021 | Jan 31, 2020 | $437.38M | Mar 30, 2022 |
| FY2021 | Jan 31, 2019 | $310.83M | Mar 30, 2021 |
| FY2020 | Jan 31, 2018 | $233.44M | Mar 30, 2020 |
| FY2019 | Jan 31, 2017 | $144.01M | Mar 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Jan 31, 2020 | $3.11M | Mar 30, 2020 |
| FY2020 | Jan 31, 2019 | $8.44M | Mar 30, 2020 |
| FY2020 | Jan 31, 2018 | $9.63M | Mar 30, 2020 |
| FY2019 | Jan 31, 2017 | $6.92M | Mar 28, 2019 |
| FY2018 | Jan 31, 2016 | $21.15M | Mar 30, 2018 |
| FY2017 | Jan 31, 2015 | $26.53M | Mar 30, 2017 |
| FY2016 | Jan 31, 2014 | $1.86M | Mar 31, 2016 |
| FY2015 | Jan 31, 2013 | $964.0K | Apr 1, 2015 |
| FY2013 | Jan 31, 2012 | $650.0K | Mar 18, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $8.98B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $7.34B | Mar 20, 2026 |
| FY2025 | Jan 31, 2024 | $5.91B | Mar 24, 2025 |
| FY2024 | Jan 31, 2023 | $4.80B | Mar 25, 2024 |
| FY2023 | Jan 31, 2022 | $3.82B | Mar 30, 2023 |
| FY2021 | Jan 31, 2021 | $3.05B | Mar 30, 2022 |
| FY2021 | Jan 31, 2020 | $2.27B | Mar 30, 2021 |
| FY2020 | Jan 31, 2019 | $1.65B | Mar 30, 2020 |
| FY2019 | Jan 31, 2018 | $1.23B | Mar 28, 2019 |
| FY2018 | Jan 31, 2017 | $917.38M | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.76B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $1.51B | Mar 20, 2026 |
| FY2025 | Jan 31, 2024 | $1.27B | Mar 24, 2025 |
| FY2024 | Jan 31, 2023 | $1.09B | Mar 25, 2024 |
| FY2023 | Jan 31, 2022 | $904.83M | Mar 30, 2023 |
| FY2021 | Jan 31, 2021 | $779.75M | Mar 30, 2022 |
| FY2021 | Jan 31, 2020 | $606.18M | Mar 30, 2021 |
| FY2020 | Jan 31, 2019 | $416.02M | Mar 30, 2020 |
| FY2019 | Jan 31, 2018 | $324.10M | Mar 28, 2019 |
| FY2018 | Jan 31, 2017 | $264.72M | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $7.21B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $5.83B | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $4.64B | Mar 20, 2026 |
| FY2026 | Jan 31, 2023 | $3.72B | Mar 20, 2026 |
| FY2025 | Jan 31, 2022 | $2.91B | Mar 24, 2025 |
| FY2024 | Jan 31, 2021 | $2.27B | Mar 25, 2024 |
| FY2023 | Jan 31, 2020 | $1.67B | Mar 30, 2023 |
| FY2021 | Jan 31, 2019 | $1.24B | Mar 30, 2022 |
| FY2021 | Jan 31, 2018 | $906.24M | Mar 30, 2021 |
| FY2020 | Jan 31, 2017 | $678.15M | Mar 30, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $439.88M | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $439.88M | Mar 20, 2026 |
| FY2025 | Jan 31, 2024 | $439.88M | Mar 24, 2025 |
| FY2024 | Jan 31, 2023 | $439.88M | Mar 25, 2024 |
| FY2023 | Jan 31, 2022 | $439.88M | Mar 30, 2023 |
| FY2021 | Jan 31, 2021 | $436.03M | Mar 30, 2022 |
| FY2021 | Jan 31, 2020 | $438.53M | Mar 30, 2022 |
| FY2021 | Jan 31, 2019 | $95.80M | Mar 30, 2021 |
| FY2019 | Jan 31, 2018 | $95.80M | Mar 28, 2019 |
| FY2018 | Jan 31, 2017 | $95.80M | Mar 30, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $4.36B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $3.45B | Mar 20, 2026 |
| FY2025 | Jan 31, 2024 | $2.74B | Mar 24, 2025 |
| FY2024 | Jan 31, 2023 | $2.21B | Mar 25, 2024 |
| FY2023 | Jan 31, 2022 | $1.73B | Mar 30, 2023 |
| FY2021 | Jan 31, 2021 | $1.30B | Mar 30, 2022 |
| FY2021 | Jan 31, 2020 | $919.66M | Mar 30, 2021 |
| FY2020 | Jan 31, 2019 | $619.20M | Mar 30, 2020 |
| FY2019 | Jan 31, 2018 | $389.37M | Mar 28, 2019 |
| FY2018 | Jan 31, 2017 | $212.88M | Mar 30, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $1.42B | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | $1.12B | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | $703.49M | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | $886.47M | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | $1.14B | Mar 25, 2024 |
| FY2023 | Jan 31, 2021 | $730.50M | Mar 30, 2023 |
| FY2021 | Jan 31, 2020 | $476.73M | Mar 30, 2022 |
| FY2021 | Jan 31, 2019 | $550.97M | Mar 30, 2021 |
| FY2020 | Jan 31, 2018 | $320.18M | Mar 30, 2020 |
| FY2019 | Jan 31, 2017 | $217.61M | Mar 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 5 | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | 4 | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | 3 | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | 3 | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | 2 | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | 0 | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | 0 | Mar 30, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 5 | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | 4 | Mar 20, 2026 |
| FY2026 | Jan 31, 2024 | 3 | Mar 20, 2026 |
| FY2025 | Jan 31, 2023 | 3 | Mar 24, 2025 |
| FY2024 | Jan 31, 2022 | 2 | Mar 25, 2024 |
| FY2021 | Jan 31, 2021 | 0 | Mar 30, 2021 |
| FY2021 | Oct 31, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Jul 31, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Apr 30, 2020 | 0 | Mar 30, 2021 |
| FY2021 | Jan 31, 2020 | 0 | Mar 30, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | 163.78M | Mar 20, 2026 |
| FY2026 | Jan 31, 2025 | 162.58M | Mar 20, 2026 |
| FY2025 | Jan 31, 2024 | 161.26M | Mar 24, 2025 |
| FY2013 | Jan 31, 2014 | 0 | Mar 18, 2014 |
| FY2013 | Jan 31, 2013 | 24.84M | Mar 18, 2014 |